GC1111

Clinical trials for GC1111 explained in plain language.

Never miss a new study

Get alerted when new GC1111 trials appear

Sign up with your email to follow new studies for GC1111, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Hunterase shows promise in Long-Term hunter syndrome control

Disease control Completed

This study looked at the long-term safety of the drug Hunterase in 30 people with Hunter syndrome, a rare genetic disorder. Participants had already been using the drug for at least 6 months. The goal was to see if the drug remains safe and effective over about a year. While it d…

Matched conditions: GC1111

Phase: PHASE3 • Sponsor: GC Biopharma Corp • Aim: Disease control

Last updated May 26, 2026 14:30 UTC

GC1111

Get alerted when new GC1111 trials appear

Hunterase shows promise in Long-Term hunter syndrome control